The purpose of this task force was to critically analyze nine non-criteria manifestations of
APS to support their inclusion as APS classification criteria. The Task Force Members …

For patients with antiphospholipid syndrome (APS), the consensus is to treat those who
develop thrombosis with long-term oral anticoagulation therapy and to prevent obstetric …

Essentials• The clinical value of IgM antibodies in thrombotic antiphospholipid syndrome
(APS) is debated.• By review of literature, we reconsidered the clinical value of IgM …

Background Immune thrombocytopenia (ITP) is a heterogeneous acquired disorder
characterized by isolated thrombocytopenia whose exact pathogenesis is not yet clear …

Adults with primary immune thrombocytopenia (ITP) may be susceptible to
thromboembolism (TE). The objective of this systematic review was to evaluate studies that …

Objectives Thrombocytopenia, a frequent clinical manifestation in patients with APS, could
be an independent predictor of recurrent thrombotic, obstetric and severe extracriteria …

The immunopathogenesis of immune thrombocytopenia: T cells s... : Current Opinion in
Hematology The immunopathogenesis of immune thrombocytopenia: T cells still take center-stage …

Antiphospholipid antibodies (aPL) are common in ITP, but their role for the occurrence of ITP-
related thrombosis is controversial. We performed a systematic review and a meta-analysis …

Abstract Essentials• Immune thrombocytopenia (ITP) is an autoimmune disorder
characterized by low platelet count.• We conducted a cohort study of 3 584 chronic ITP …

This meta-analysis describes the incidence rate of arterial and venous thromboembolism
(ATE and VTE) in patients with immune thrombocytopenia (ITP), and the relative risk of ATE …